Search Results - "Baker, Stuart G."

The Role of the Extracellular Matrix in Cancer Prevention.

Authors: Baker, Stuart G. Sauter, Edward R.

Source: Cancers. May2025, Vol. 17 Issue 9, p1491. 12p.

Prostate cancer screening: Decision-making when MRI results are inconclusive for cancer (PI-RADS 3).

Authors: Baker, Stuart G.¹ (AUTHOR) profstu@outlook.com

Source: Urologic Oncology. Jul2026, Vol. 44 Issue 7, p243-247. 5p.

The efficient stored specimen design for evaluating multiple screening technologies: Application to multicancer detection tests.

Authors: Baker, Stuart G. Katki, Hormuzd A.

Source: Journal of Medical Screening. Jun2026, Vol. 33 Issue 2, p79-83. 5p.

Quantifying Overdiagnosis for Multicancer Detection Tests: A Novel Method.

Authors: Baker, Stuart G.¹ (AUTHOR) sb16i@nih.gov

Source: Statistics in Medicine. 12/30/2024, Vol. 43 Issue 30, p5935-5943. 9p.

Calibrating machine learning approaches for probability estimation: A short expansion.

Authors: Ojeda, Francisco M. Baker, Stuart G. Ziegler, Andreas

Source: Statistics in Medicine. 9/20/2024, Vol. 43 Issue 21, p4212-4215. 4p.

Multiple Discoveries in Causal Inference: LATE for the Party.

Authors: Baker, Stuart G. Lindeman, Karen S.

Source: Chance. Apr2024, Vol. 37 Issue 2, p21-25. 5p.

Local average treatment effects with binary outcomes.

Authors: Baker, Stuart G Lindeman, Karen S

Source: American Journal of Epidemiology. Dec2025, Vol. 194 Issue 12, p3399-3401. 3p.

Comments on "sensitivity of estimands in clinical trials with imperfect compliance" by Chen and Heitjan.

Authors: Baker, Stuart G. Lindeman, Karen S.

Source: International Journal of Biostatistics. Nov2024, Vol. 20 Issue 2, p435-436. 2p.

Modeling the mean time to interval cancer after negative results of periodic cancer screening.

Authors: Baker, Stuart G.¹ (AUTHOR) sb16i@nih.gov

Source: Statistics in Medicine. 3/15/2021, Vol. 40 Issue 6, p1429-1439. 11p.

Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening.

Authors: Baker, Stuart G Kramer, Barnett S

Source: Biomarker Insights. 8/4/2020, p1-8. 8p.

Prediagnostic evaluation of multicancer detection tests: design and analysis considerations.

Authors: Baker, Stuart G Etzioni, Ruth

Source: JNCI: Journal of the National Cancer Institute. Jun2024, Vol. 116 Issue 6, p795-799. 5p.

Maximum likelihood estimation with missing outcomes: From simplicity to complexity.

Authors: Baker, Stuart G.¹ (AUTHOR) sb16i@nih.gov

Source: Statistics in Medicine. 9/30/2019, Vol. 38 Issue 22, p4453-4474. 22p.

Adjusting for non-compliance and contamination with a more plausible assumption.

Authors: Baker, Stuart G Lindeman, Karen S

Source: Journal of Medical Screening. Feb2026, p1.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trials.

Authors: Baker, Stuart G.¹ sb16i@nih.gov

Source: Statistics in Medicine. 2/20/2018, Vol. 37 Issue 4, p507-518. 12p.

The summary test tradeoff: a new measure of the value of an additional risk prediction marker.

Authors: Baker, Stuart G.¹

Source: Statistics in Medicine. 12/10/2017, Vol. 36 Issue 28, p4491-4494. 4p.

The latent class twin method.

Authors: Baker, Stuart G.¹, sb16i@nih.gov

Source: Biometrics; Sep2016, Vol. 72 Issue 3, p827-834, 8p